LOIs for Lung Cancer Discovery Award

The American Lung Association research program invests in the brightest, pioneering minds with immense potential to drive innovation, discover the unknown, and improve the lives of those with lung cancer.

To that end, it invites applications for the Lung Cancer Discovery Award. The award's objective is to support independent investigators conducting clinical, laboratory, epidemiological, or any groundbreaking project to revolutionize our current understanding of lung cancer and improve diagnostic, clinical, and treatment methods. Grants of $100,000 per year for up to two years will be awarded to support meritorious research projects with the potential to: significantly improve and transform diagnostic and therapeutic paradigms; foster innovation, use novel approaches; and/or accelerate progress in lung cancer research that improves patient care and helps save lives.

To be eligible, applicants must hold a doctoral degree, have a faculty appointment at an academic institution (including research institutions not formally associated with a university), and have completed a training fellowship. Applicants must be United States citizens or foreign nationals holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), a temporary worker in a specialty occupation (H-1B), Canadian or Mexican citizen engaging in professional activities (TN), Australians in Specialty Occupation (E-3), or temporary worker with extraordinary abilities in the sciences (O1). At the time of application and throughout the award, applicants must be employed by a U.S. institution.

Letters of intent are due September 15, 2022, and upon review, selected applicants will be invited to submit a full application due December 15, 2022.

For complete program guidelines and application instructions, see the American Lung Association website.